Hollister Biosciences Logo White

Hollister Biosciences

CSE: HOLL | OTC: HSTRF | FWB: HOB

Canadian cannabis firm Hollister Biosciences entered into a definitive agreement to acquire Alphamind Brands, and closed the acquisition in April 2020. Alphamind are conducting R&D into psilocybin-based drug therapies, seeking to build an IP portfolio in the psychedelic medicine space. 

[mstock id="3020"]
[mstock id="3021"]

Join our Newsletter

Get the latest Company updates delivered to straight to your inbox.